Position in RIGL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,705,495
-$3,445,949 QoQ
Shares Held
145,846
-56.9% QoQ
Ownership
0.781%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#21
of 156 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. RIGL ranks #76 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in RIGL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,705,495 | 145,846 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,151,444 | 338,441 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $23,085,755 | 539,009 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $13,434,340 | 474,209 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,428,633 | 236,446 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,618,616 | 201,146 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,041,105 | 299,709 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,296,686 | 141,946 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,191,456 | 144,946 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,989,882 | 2,020,191 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,911,427 | 1,318,226 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,222,372 | 1,131,826 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,039,652 | 1,581,126 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,611,907 | 1,978,718 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,197,750 | 798,500 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,540,166 | 1,305,226 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $411,885 | 364,500 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $647,036 | 216,400 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $192,390 | 72,600 | Shares | Sole | 2022-02-11 | |
| 2021-03-31 | $754,110 | 220,500 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $7,310,149 | 2,088,614 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $8,112,993 | 3,380,414 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $10,646,359 | 5,817,683 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,566,231 | 4,209,123 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||